Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,564 | -3,273 | -1,533 | -8,154 | -6,480 |
| Depreciation Amortization | 101 | 43 | 22 | 2,066 | 1,976 |
| Accounts receivable | 72 | -80 | -1 | -9 | -8 |
| Accounts payable and accrued liabilities | 407 | -171 | -199 | 115 | -81 |
| Other Working Capital | 527 | 13 | -176 | 114 | -133 |
| Other Operating Activity | 36 | 578 | 357 | 1,798 | 1,956 |
| Operating Cash Flow | $-4,422 | $-2,889 | $-1,529 | $-4,071 | $-2,770 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -36 | -32 | -220 | N/A |
| Net Acquisitions | -2,187 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,223 | $-36 | $-32 | $-220 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 0 | 1,279 | 1,279 |
| Debt Repayment | -8 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 13,816 | 13,816 |
| Other Financing Activity | -252 | -209 | -83 | -751 | -187 |
| Financing Cash Flow | $-260 | $-209 | $-83 | $14,344 | $14,908 |
| Beginning Cash Position | 11,414 | 11,414 | 11,414 | 1,361 | 1,361 |
| End Cash Position | 4,509 | 8,279 | 9,769 | 11,414 | 13,498 |
| Net Cash Flow | $-6,905 | $-3,135 | $-1,645 | $10,053 | $12,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,422 | -2,889 | -1,529 | -4,071 | -2,770 |
| Capital Expenditure | -36 | -36 | -32 | -220 | N/A |
| Free Cash Flow | -4,458 | -2,925 | -1,561 | -4,291 | -2,770 |